Anna Babin of the Pharmaceutical Sciences Division on MRI detected steroid-induced changes in the lungs of mice following bleomycin insult.
Jelena Jovanovic of the Division of Genetics & Molecular Medicine on improving the outcome in acute promyelocytic leukaemia (APL) by optimising monitoring for minimal residual disease (MRD) and elucidating mechanisms of resistance to molecularly targeted therapy.
Madeleine Oudin of the Wolfson Centre for Age Related Diseases on endocannabinoids regulating the migration of subventricular zone-derived neuroblasts in the post-natal brain.
Rojeen Shahni of the Division of Reproduction & Endocrinology on NSA2, a novel marker of diabetic nephropathy and a potential regulator of TGFβ1.
Frederick Warren of the Division of Nutritional Sciences on the interactions of alpha-Amylase with the surface of starch granules.
Jana Koth of Randall Division of Cell & Molecular Biophysics on how muscles get their shape: collective cell migrations in morphogenesis.
Michelle Connolly of the Division of Asthma, Allergy & Lung Biology on Hypoxic pulmonary vasoconstriction: key role for intracellular Ca2+ release.
Ross Pollock of the Division of Applied Biomedical Sciences on the effect of whole body vibration on motor unit threshold and neuromuscular performance.
Mieke Van Hemelrijck of the Division of Cancer Studies on the risk of thromboembolic diseases in men with prostate cancer: Results from the population-based PCBaSe Sweden.
Rita Hendricusdottir of the MRC centre for Developmental Neurobiology on the function and regulation of Drebrin in dendritic spines.
Abdullah Cim of the Division of Gene & Cell Based Therapy on in vivo transdifferentiation of liver cells Into pancreatic beta-cells.
John Labbadia of the Division of Genetics & Molecular Medicine on why the neuronal chaperone HSJ1a preferentially interacts with insoluble mutant Huntingtin, reduces aggregate load, and improves phenotype when over-expressed in the R6/2 mouse model of HD.
Saydul Alam of the Cardiovascular Division on why HDAC3 is crucial for immunomodulation via galectin-9 expression.
James Cole of the Institute of Psychiatry on why depressive illness severity is associated with widespread decreases in white matter integrity: A tract-based spatial statistics study.
Jennifer Nicholas of the Division of Health & Social Care Research on improving the outcome in acute promyelocytic leukaemia (APL) by optimising monitoring for minimal residual disease (MRD) and elucidating mechanisms of resistance to molecularly targeted therapy.
Shuzhi Zhou of the Division of Reproduction & Endocrinology on the neurobiology of puberty-onset in the eusocial naked mole-rat (Heterocephalus glaber).
Abderrezzaq Soltani of the Pharmaceutical Sciences Division on Investigation into the physico-chemical and biological properties of the proteasomal specific inhibitor PSI.
David Berry of the Division of Imaging Sciences on tripodal hexadentate chelator for fast room temperature labelling with 67/68Ga.
Laura Lleras of the Dental Institute on Molecular analysis of sensory organ precursors in the chick.
Hina Shariff of the Division of Immunology, Infection & Inflammatory Disease on why intermittent antibody-based combination therapy achieves indefinite cardiac allograft survival in sensitised recipients.
Yuen Fei Wong of Division of Gene & Cell Based Therapy on retinoic acid activity in renal collecting duct: potential target gene and anti-fibrotic potential.
King's Health Schools Graduate Showcase 2010: Yuen Fei Wong of Division of Gene & Cell Based Therapy on retinoic acid activity in renal collecting duct: potential target gene and anti-fibrotic potential.